Poland: new limits on pharmaceutical samples 1

Poland

From 1 January 2012, doctors will only be able to obtain a medicinal product sample for 2 years after first requesting it, and will be limited to a maximum of 4 samples per year

The change affects pharmaceutical companies affiliated to the European Federation of Pharmaceutical Industries and Associations (EFPIA) and results from its introduction of an amended Code of Advertising Prescription-only Medicinal Products.

A similar change will be introduced to the Code of Good Marketing Practice for the Pharmaceutical Industry, Cooperation with Representatives of Health and Patient Organizations INFARMA, whose signatories form a large proportion of the companies producing new medicinal products for the Polish market.

The underlying legal position is unchanged, limiting doctors to a maximum of 5 samples of the smallest package of the medicinal product available in Poland. As the law will thus be more liberal than the Code, companies that are not affiliated to EFPIA or INFARMA will have a larger sample allowance.